Pablo B. Nery
YOU?
Author Swipe
View article: Iodinated Adhesive Drapes for Repeat Cardiac Implantable Device Implantation
Iodinated Adhesive Drapes for Repeat Cardiac Implantable Device Implantation Open
Importance One potential pathophysiological mechanism for cardiac implantable electronic device (CIED) infections is pocket contamination during the implantation procedure. Preventing contamination at this stage may significantly reduce th…
View article: Contemporary outcomes of implantable cardioverter defibrillator patients on amiodarone
Contemporary outcomes of implantable cardioverter defibrillator patients on amiodarone Open
Background Patients with implantable cardioverter defibrillators (ICDs) frequently experience shocks due to arrhythmias. Current treatment options include ventricular tachycardia (VT) ablation, clinical follow-up, and antiarrhythmic medica…
View article: Effectiveness of a Standardized Approach to Repeat Paroxysmal Atrial Fibrillation Ablation: Insights Into the Value of Extrapulmonary Vein Targets
Effectiveness of a Standardized Approach to Repeat Paroxysmal Atrial Fibrillation Ablation: Insights Into the Value of Extrapulmonary Vein Targets Open
A comprehensive protocol for repeat PAF ablation resulted in arrhythmia-free survival at 1 year in 53% of patients. Durably isolated PVs were observed in 26.5% of cases. None of the ablation protocol's steps was suggested to independently …
View article: Report of cardiac electronic device implant complications over a 7-year study period
Report of cardiac electronic device implant complications over a 7-year study period Open
Background The global placement of cardiac implantable electronic devices (CIEDs) is on the rise. Complications linked to device implantation present a substantial burden on healthcare systems and patients alike. It is imperative to compre…
View article: High‐power short‐duration versus low‐power long‐duration ablation for pulmonary vein isolation: A substudy of the AWARE randomized controlled trial
High‐power short‐duration versus low‐power long‐duration ablation for pulmonary vein isolation: A substudy of the AWARE randomized controlled trial Open
Introduction Pulmonary vein isolations (PVI) are being performed using a high‐power, short‐duration (HPSD) strategy. The purpose of this study was to compare the clinical efficacy and safety outcomes of an HPSD versus low‐power, long‐durat…
View article: Do barrier dressings reduce cardiac implantable device infection: Protocol for a randomized controlled trial (BARRIER-PROTECT)
Do barrier dressings reduce cardiac implantable device infection: Protocol for a randomized controlled trial (BARRIER-PROTECT) Open
This is the first randomized controlled trial to assess the effectiveness of using a barrier adhesive draping on reducing the end-of-procedure pocket swab culture positivity. In this study, we are exploring a low-cost intervention that may…
View article: High-Power Short-Duration vs Low-Power Long-Duration Ablation for Pulmonary Vein Isolation: A Substudy of the AWARE Randomized Controlled Trial
High-Power Short-Duration vs Low-Power Long-Duration Ablation for Pulmonary Vein Isolation: A Substudy of the AWARE Randomized Controlled Trial Open
Background Pulmonary vein isolations (PVI) are being performed using a high-power, short duration (HPSD) strategy. The purpose of this study was to compare the clinical efficacy and safety outcomes of a HPSD vs low-power long duration (LPL…
View article: Investigating the treatment phenotypes of cardiac sarcoidosis: A prospective cohort study
Investigating the treatment phenotypes of cardiac sarcoidosis: A prospective cohort study Open
The initial response rate to prednisone was high with all patients showing a reduction in FDG uptake and 19/21 meeting a PET definition of >25 % response. Secondly, a trial of therapy discontinuation was able to classify 7/19 patients as a…
View article: Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review
Corticosteroid and Immunosuppressant Therapy for Cardiac Sarcoidosis: A Systematic Review Open
Background Corticosteroid therapy for the treatment of clinically manifest cardiac sarcoidosis is generally recommended. Our group previously systematically reviewed the data in 2013; since then, there has been increasing quality and quant…
View article: Remote-only monitoring for patients with cardiac implantable electronic devices: a before-and-after pilot study
Remote-only monitoring for patients with cardiac implantable electronic devices: a before-and-after pilot study Open
ClinicalTrials.gov, no. NCT02585817.
View article: Differences in Healthcare Use Between Patients With Persistent and Paroxysmal Atrial Fibrillation Undergoing Catheter‐Based Atrial Fibrillation Ablation: A Population‐Based Cohort Study From Ontario, Canada
Differences in Healthcare Use Between Patients With Persistent and Paroxysmal Atrial Fibrillation Undergoing Catheter‐Based Atrial Fibrillation Ablation: A Population‐Based Cohort Study From Ontario, Canada Open
Background Patients with persistent atrial fibrillation (AF) undergoing catheter‐based AF ablation have lower success rates than those with paroxysmal AF. We compared healthcare use and clinical outcomes between patients according to their…